Related Experiment Videos
Kidney transplantation in children
1Department of Pediatrics, UCLA School of Medicine.
Insights
Pediatric kidney transplant success has risen significantly, with 1-year graft survival nearing 90%. Key factors include improved matching, immunosuppression, and rejection management, though disease recurrence remains a challenge.
Area of Science:
- Pediatric Nephrology
- Transplantation Immunology
Background:
- Pediatric kidney transplantation outcomes have improved over the last decade.
- Histocompatibility testing, immunosuppressive management, and rejection protocols have advanced significantly.
Purpose of the Study:
- To summarize the current state of pediatric kidney transplantation.
- To highlight key factors influencing graft survival and complications.
Main Methods:
- Review of recent advancements in pediatric kidney transplant care.
- Analysis of factors affecting graft survival and post-transplant complications.
Main Results:
- 1-year graft survival rates now exceed 90%.
- Optimal recipient and donor age is over six years.
- Recurrence of primary disease causes approximately 5% of graft loss.
Conclusions:
- Sequential immunosuppressive protocols, including corticosteroids, azathioprine, and cyclosporin A, are effective in children.
- Common post-transplantation complications include rejection, infection, hypertension, growth retardation, and noncompliance.
Abstract:
Over the past decade, the success rate of pediatric kidney transplantation has dramatically increased, based on improvements in histocompatibility testing, immunosuppressive management, and diagnosis and treatment of rejection. The 1-year graft survival rate now approaches 90%. The optimal age for recipients as well as for donor organs is greater than six years. Recurrence of primary disease in the graft accounts for approximately 5% graft loss in children. Sequential immunosuppressive protocols have been particularly successful in children, and maintenance immunosuppression routinely includes corticosteroids, azathioprine, and cyclosporin A. Posttransplantation complications include rejection, infection, hypertension, growth retardation, and noncompliance.